Correspondence:
Received 2024 Sep 11; Revised 2024 Oct 10; Accepted 2024 Oct 17; Collection date 2024 Oct.
Freeze-drying, also known as lyophilization, is widely used to preserve proteins in a dry state for long-term storage and transportation. These frozen-dried bioproducts facilitate transportation to distant locations without the need for cold-chain storage and reduce point-of-care labor costs by eliminating the need for on-site mixing of reagents. Lyophilized protein powder can be stocked for future outbreaks, and this strategy can even be used in experiments with more extended time scales [
Lyophilization is an ideal process to convert protein solution into a solid form. The freeze-dried protein powders will increase their shelf-life. However, protein integrity is compromised since the drying process exerts pressure and causes irreversible conformational changes in the protein structure, which leads to the inactivation of the protein functions. During reconstitution of the freeze-dried protein powder, moisture causes the freeze-dried proteins to undergo disulphide interchange and other reactions, which lead to inactivation [
Lyoprotectants are added to protein formulations to protect them from freeze-drying stresses. They achieve this by reducing the water content and maintaining proper protein structure and stability during the process. The choice of lyoprotectant depends on the protein characteristics, freezing conditions, and desired final product properties. Commonly used lyoprotectants include sugars, polyols, amino acids, and surfactants [
A comprehensive search was performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The search was conducted in electronic databases such as PubMed, Web of Science (WOS), and Scopus. To ensure only current studies were used, the search was restricted to publications from 2018 to 2024. Three sets of keyword terms were used for the searching process: “lyoprotectants” or “protective agents” or “chemical additives”; “protein stabilization” or “conformational stability” or “protein activity”; and” lyophilization” or “freeze-drying” or “cryodesiccation”. The title and abstract of all articles were screened individually and duplicate articles were excluded. The references of all retrieved and relevant articles were also reviewed to ensure more thorough findings. The search was restricted to published articles and journal clinical trials in English language.
The PRISMA flow diagram of study selection.
Two authors (V.K. and N.A.H.A.) independently recorded data from every included study. Any disagreement between the two authors was resolved by discussion with other authors. Then, the following data were extracted: study design, type lyoprotectants, effect on protein models, and alternative freeze-drying method.
The inclusion and exclusion criteria outlined are essential for determining the scope of the systematic review focused on lyoprotectants for protein stabilization during freeze-drying. The review considered studies published between 2018 and 2024. This time frame ensures that the review was based on the most recent and relevant research, reflecting the latest advancements in the field. Only full-text articles published in peer-reviewed scientific journals were included. This criterion was crucial for ensuring the credibility and scientific rigor of the studies being reviewed. This review included articles published in English. This limitation was set to facilitate comprehensive understanding and accessibility of the research findings. This review encompassed studies conducted globally, allowing for a wide range of data and insights from various geographical contexts. Only reviews of published original research articles in indexed journals were included. This criterion ensured that the review was grounded in established scientific evidence rather than anecdotal or unverified claims.
For the exclusion criteria, articles that were not present in indexed journals, such as online articles, review articles, letters to editors, perspectives, commentaries, and news reports, were excluded. This helped maintain the quality and reliability of the sources included in the review. Articles published in languages other than English were not considered. This exclusion was necessary due to the challenges of accurately interpreting and translating scientific content, which could lead to misinterpretation of the findings. By adhering to these inclusion and exclusion criteria, the systematic review aimed to compile a comprehensive and credible body of evidence regarding the effectiveness of lyoprotectants for protein stabilization during the freeze-drying process.
This systematic review was aimed to screen and identify potential lyoprotectants. Discovering new lyoprotectants is important for several reasons, primarily related to enhancing the effectiveness, stability, and safety of the lyophilization (freeze-drying) process, which is widely used for preserving sensitive biological materials, pharmaceuticals, and food products. As formulations become more complex, containing multiple active ingredients or excipients, discovering new lyoprotectants that are compatible with these formulations becomes crucial. Effective lyoprotectants facilitate faster and more complete reconstitution of the lyophilized product back into solution. This is particularly important in clinical settings, where quick preparation is often necessary. As new classes of therapeutics, such as mRNA-based drugs and gene therapies, are developed, they may require unique lyoprotectants to maintain their stability and effectiveness.
The database search yielded 79 results in total. Out of these, 42 articles failed to match the inclusion criteria, and 17 were discarded as duplicates. Ultimately, 20 studies were included in this review. We discovered plausible lyoprotectants from multiple sources that can preserve various protein models during the freeze-drying process after reviewing and contrasting our databases. According to the data, we list the most commonly used lyoprotectant, new potential protein stabilizers, effectiveness of combining two or more lyoprotectants, and interactions between the lyoprotectants and protein.
List of studies included.
| Author | Lyoprotectants | Protein Model | References |
|---|---|---|---|
| S. H. Kim et al., 2023 | Raffinose | [ | |
| S. H. Kim et al., 2023 | Calcium ions (Ca+) |
| [ |
| J. Fortuin et al., 2024 | Spirulina (Arthrospira platensis) protein isolate (SPI) | [ | |
| M. Li et al., 2023 | Sucrose, Trehalose, Mannitol | mRNA-lipid nanoparticles (LNPs) | [ |
| M. Megoura et al., 2023 | Sucrose, Trehalose | Vegetal diamine oxidase (vDAO) | [ |
| D. G. Farfan Pajuelo et al., 2023 | Mannitol, Glucose | [ | |
| Y. Liu et al., 2024 | Trehalose, Poly-vinylpyrimidine, Sorbitol | [ | |
| K. Ahlgren et al., 2023 | Sucrose, Trehalose | Protein myoglobin (Mb) | [ |
| M. Z. Nafchi et al., 2018 | Sucrose, Trehalose, Glucose, Lactose, Dextran-40, Monosodium glutamate (MSG) | [ | |
| K. M. Wilding et al., 2019 | Ficoll/maltitol/DMSO (FMD), Dextran/maltitol/DMSO (DMD), Dextran | [ | |
| T. P. Holm et al., 2021 | Amino acids, Monosaccharides, Disaccharides, Trisaccharides | α-amylase, α-lactalbumin, albumin from human serum, albumin from human serum (fatty acid free, globulin free), β-lactoglobulin, bovine serum albumin, deoxyribonuclease I, γ-globulin, lactase, lysozyme, myoglobin | [ |
| I. Mendonça-da-Silva et al., 2017 | Sucrose | Trivalent Antivenom (AV) | [ |
| C. Bou-Mitri and S. Kermasha, 2018 | Dextran 6kDa, Sucrose, Mixture of Sodium benzoate, Potassium sorbate (BSKS), and Sorbitol | Laccase from | [ |
| M. J. Hammerling et al., 2021 | Sucrose, Trehalose, Dextran, Sucrose-Trehalose mix | GoTaq RT-qPCR kit | [ |
| W. Ngamcherdtrakul et al., 2018 | Trehalose | Antibody (trastuzumab)-conjugated mesoporous silica nanoparticles decorated with a copolymer of polyethylenimine and polyethyleneglycol | [ |
| M. A. Hamaly et al., 2018 | Mannitol, Trehalose, Combinations of trehalose/mannitol | Antibody rituximab | [ |
| S. Darniadi, I. Ifie, P. Ho, and B. S. Murray, 2019 | Maltodextrin (MD), Trehalose, Whey protein isolate (WPI) | Anthocyanin | [ |
| V.-V. Auvinen et al., 2019 | PEG 6000, Trehalose | Hepatocellular (HepG2) cell spheroid | [ |
| A. Arsiccio et al., 2019 | Sucrose, Trehalose, Cellobiose, b-cyclodextrin, Mannitol, Histidine, Sucrose-Trehalose | Lactate dehydrogenase (LDH) | [ |
| X. Chen and S. Wang, 2018 | Antifreeze glycopeptide analogues (GAPP) |
| [ |
Lyoprotectants can be broadly classified into several categories based on their chemical compositions and functional properties, each serving a specific role in stabilizing proteins during lyophilization.
The classification of identified lyoprotectants.
| Classification | Lyoprotectants |
|---|---|
| Monosaccharides | B-D-(+)-Allose, D-(−)-Arabinose, DL-Arabinose, L-(+)-Arabinose |
| Disaccharides | D-(+)-Cellobiose, 3-Gentiobiose, Isomaltulose MH, Lactose AH, Lactose MH, B-Lactose, Lactulose, Maltose MH, Maltulose MH, Melibiose, Palatinose hydrate, Sucralose, Sucrose, Trehalose, D-(+)-Turanose, Isomalt, Lactitol MH, Maltitol |
| Trisaccharide | 1-Kestose, Maltotriose, D-(+)-Melezitose MH, D-(+)-Melezitose hydrate, D-(+)-Raffinose PH, Maltotriitol |
| Amino acids | Alanine, Arginine, Glycine, Lysine, Proline, Serine |
| Solubilizers | b-cyclodextrin, PEG 6000 |
| Polysaccaride | Poly-vinylpyrimidine, Dextran-40, Dextran 6kDa, Dextran |
| Surfactants | Tween-20 |
| Ions | Calcium ions (Ca+) |
| Chemical additives | Mixture of Sodium benzoate, Potassium sorbate (BSKS), Monosodium glutamate (MSG) |
| Antiplasticized polymeric glasses | Ficoll/maltitol/DMSO (FMD), Dextran/maltitol/DMSO (DMD) |
| Protein isolates | Spirulina (Arthrospira platensis) protein isolate (SPI), |
The important underlying mechanism of lyoprotectant is the interactions between the lyoprotectant and protein. Bonding between lyoprotectant and protein is another key contributor to enhance the stability of the protein conformation in the post-drying process. Hydrogen bonding with proteins is one of the key mechanisms by which lyoprotectants stabilize proteins. Lyoprotectants like sugars (e.g., sucrose, trehalose) and polyols (e.g., glycerol, sorbitol) can form hydrogen bonds with the polar groups on the surface of proteins. This bonding mimics the hydrogen bonding interactions that water would normally provide [
The types of interaction between lyoprotectant–protein.
| Interactions | Lyoprotectant | Mechanism | References |
|---|---|---|---|
| Hydrogen bonding | Trehalose | Form hydrogen bonds with the protein’s polar groups, such as the amide groups in the peptide backbone and the hydroxyl groups in the side chains. | [ |
| Hydrophobic interactions | PEG | PEG interact with the protein’s hydrophobic regions, such as the non-polar amino acid residues. These interactions can prevent protein aggregation and maintain the protein’s native conformation. | [ |
| Electrostatic interactions | Arginine | Arginine and lysine can interact with the protein’s charged amino acid residues, such as aspartic acid and glutamic acid, in order to prevent denaturation during the drying process. | [ |
| Osmoprotectant | Trehalose and Sucrose | Protect proteins from osmotic stress during the drying process and maintain the protein’s hydration state by preventing water loss during the drying process, which can cause protein denaturation. | [ |
Tg′ the glass transition temperature value is a vital attribute to consider when choosing an appropriate lyoprotectant during the lyophilization (freeze-drying) process for protein stabilization. Proteins can denature during the freeze-drying process because of dehydration and temperature stress. To avoid that, the product temperature should always remain below Tg′, since exceeding this limit might imply structural changes in the freeze-concentrated amorphous phase which can compromise protein stability. A study by Searles et al. (2001) has demonstrated that in the prevention of structural collapse of freeze-dried cake and denaturation of protein in primary drying, the temperature should be kept below Tg′. The above Tg′ lysozyme and other proteins aggregated so extensively during lyophilization that they lost their activity [
The freeze-concentrated phase of the ice becomes rubbery rather than less rigid when temperatures exceed Tg′. It leads to total collapse of the product, making its quality and mechanical stability poor in lyophilization. Studies by Tang and Pikal (2004) showed that products lyophilized above Tg′ resulted in marked collapse with poor reconstitution properties and compromised drug quality. The collapse temperature was highly correlated to Tg′, and lyoprotectants that increased Tg′ (sugars) helped to address this challenge. The higher the Tg′ of a formulation, the more likely it is that the protein will be stable during lyophilization. Higher Tg′ formulations perform better in long-term storage and have demonstrated the capacity to withstand temperature cycling [
According to an experiment by Tobias and team, disaccharides-derived polyols such isomalt, lactitol monohydrate, and maltitol have an acquired amorphous state, high Tg′, and are non-reducing because they lack a carbonyl group. These lyoprotectants performed consistently well against 12 model proteins, successfully preserving the protein’s integrity [
List of lyoprotectant and Tg′ values.
| Class of Excipients | Lyoprotectant and Tg′ Value | Application as Lyoprotectant |
|---|---|---|
| Monosaccharides | D-(−)-Arabinose: ~−45 °C, DL-Arabinose: ~−45 °C, L-(+)-Arabinose: ~−45 °C, D-(−)-Fructose: ~−41 °C, D-(+)-Galactose: ~−36 °C, D-Glucose: ~−42 °C, D-(+)-Glucose: ~−42 °C, D-(+)-Mannose: ~−36 °C, L-Rhamnose: ~−37 °C, D-(−)-Ribose: ~−39 °C, D-(−)-Tagatose: ~−36 °C, D-(+)-Xylose: ~−46 °C, DL-Xylose: ~−46 °C, Inositol: ~−30 °C, D-(−)-Mannitol: ~−38 °C, D-Sorbitol: ~−32 °C, Xylitol: ~−35 °C, Glucose: ~−42 °C, Fructose: ~−41 °C, Mannose: ~−36 °C | Monosaccharides usually have lower Tg′ values and are often used in combination with other excipients. |
| Disaccharides | Lactose AH (Anhydrous): ~−28 °C, Lactose MH (Monohydrate): ~−31 °C, Sucrose: ~−32 °C, Trehalose: ~−27 °C, Maltose: ~−34 °C | Disaccharides are commonly used as lyoprotectants due to their relatively high Tg′ values compared with monosaccharides, which help maintain stability in the glassy state. |
| Trisaccharide | Raffinose: ~−35 °C | Trisaccharides like raffinose have Tg′ values that are somewhat intermediate between mono- and disaccharides, providing different stabilization characteristics. |
| Polysaccaride | Poly-vinylpyrimidine: 100 °C to 175 °C, Dextran-40: −15 °C to −20 °C, Dextran 6 kDa: −25 °C to −30 °C, Dextran: −10 °C to −20 °C (Tg′ increases with molecular weight due to reduced molecular mobility.) | PVP has a high Tg′ and is excellent for forming stable glassy matrices, providing good protection for proteins during freeze-drying. Dextrans have Tg′ values that vary with molecular weight, with higher molecular weights generally having higher Tg′ values. |
| Amino acids | Glycine: ~−35 °C (when used in combination with other excipients), Alanine: ~−45 °C, Proline: ~−52 °C | Amino acids generally have lower Tg′ values and are often used in combination with other stabilizers to achieve optimal protective effects. |
| Solubilizers | b-cyclodextrin, PEG 6000: −55 °C to −65 °C. | β-Cyclodextrin does not have a typical Tg′ value but can form glassy mixtures with other excipients. PEG 6000 has a relatively low Tg′, making it less effective as a sole lyoprotectant but useful as a plasticizer. |
The selection of a lyoprotectant for a protein comprised several key requirements such Tg′ value, water replacing ability, ability to maintain the structural stability, and ability to enhance reconstitution [
Furthermore, during freeze-drying, water is removed from the system, which can lead to the denaturation or aggregation of proteins due to the loss of hydration shells and the stabilization provided by water [
Lyoprotectants play a critical role in contributing to the structural stability of freeze-dried products, which is essential for the preservation of the biological activity, integrity, and overall quality of the product. The removal of water can lead to the collapse of the freeze-dried cake, resulting in a dense, non-porous structure. This collapse can adversely affect the reconstitution time and solubility of the product [
Structural integrity of the lyophilized product plays a major role in ensuring the protein stabilization. Achieving “uniform and elegant” cake appearance, amorphous nature, large porosity, and better solubility are the most important criteria to be met to produce a stable lyophilized product. Unstable cake commonly has a visual attribute of cracking, shrinkage, slanted cake, droplet formation, bubble, melt-back, fogging, and a puffed surface. Results revealed several lyoprotectants that contributed to better cake formation. A mixed lyoprotectant composed of sucrose, trehalose, and mannitol was added to mRNA-LNPs upon lyophilization and exhibited ginger root-shaped rigid structure with large porosity, good particle size distribution, encapsulation rate, and mRNA integrity [
Another vital aspect that we explored was the combined application of lyoprotectants and the influence on protein activity and structural stability. A comprehensive protection achieved through the combination of various excipients not only stabilizes proteins during freeze-drying but also addresses challenges related to transport and storage [
The earliest lyoprotectants were simple sugars, with sucrose and trehalose being among the most commonly used. Studies from the 1960s and 1970s recognized the stabilizing effects of these sugars on biological materials. Other disaccharides, like lactose and maltose, also began to be used as lyoprotectants. The use of these sugars was largely empirical, based on their availability and their effectiveness in empirical studies of freeze-dried products. The use of synthetic polyols and polymers like polyvinylpyrrolidone (PVP) and polyethylene glycol (PEG) emerged in the late 1980s and 1990s. These polymers offered new mechanisms of stabilization by enhancing the viscosity of the surrounding medium, which helped in reducing protein aggregation and degradation [
In this review, 15 out 19 screened articles had selected sucrose or trehalose or both sucrose and trehalose as lyoprotectants. These non-reducing disaccharides are well known and predominantly used as protein stabilizers due to their magnificent ability to replace water content in the protein model. This phenomenon is explained through water replacement theory stating that sugars substitute water molecules in their interactions with the polar groups of membrane lipids. The main gel of the membrane does not rise to the temperature of the fluid phase transition due to these interactions, which preserve the distance between lipids. Consequently, dry membranes do not undergo a phase shift during rehydration and maintain their fluid condition at physiological temperatures [
The hydroxyl groups (-OH) of disaccharides create hydrogen bonds with protein functional groups. A study conducted by S. Dean Allison and team concluded that hydrogen bonding of disaccharides directly to dried lysozyme, and not the trapping of water by the sugar, prevents the unfolding caused by freeze-drying stress [
Conducting a systematic review on the effectiveness of lyoprotectants in protein stabilization during lyophilization poses numerous challenges and restrictions at different stages of the review process, such as data search, screening, and analysis. These problems can have an impact on the review’s results’ strength and dependability. This section discusses the limitations and challenges faced from the initial to final stages of the review preparation.
Firstly, there is a limited availability of specific studies. Although lyoprotectants have been extensively studied, there is a shortage of research specifically focusing on proteins or combinations of lyoprotectants. This scarcity in focused studies limits the available data for a thorough and comprehensive analysis. Moreover, niche applications or specialized protein–lyoprotectant combinations may be underrepresented, leading to potential knowledge gaps. Different studies often use varied terminologies when describing lyoprotectants, protein stabilization mechanisms, and lyophilization methods. These inconsistencies can make it difficult to conduct systematic searches and may result in the exclusion of relevant studies. The lack of standardized terms may also complicate the comparison and synthesis of data from different sources.
Furthermore, language barriers are a vital limitation. Most systematic reviews limit their scope to English-language articles, which can exclude valuable research published in other languages. This can lead to geographical and cultural biases in the data, as important studies from non-English-speaking countries might be left out of the analysis, not excluding the fact about the heterogeneity of studies. The studies on lyoprotectants vary greatly in terms of their design, lyoprotectant concentrations, types of proteins, drying protocols, and evaluation methods. This diversity introduces a level of complexity that hinders the ability to conduct meta-analyses or draw generalized conclusions. The differences in experimental setups make it difficult to compare outcomes across studies reliably.
In addition, many studies report qualitative outcomes, such as visual assessments of cake structure or protein aggregation, rather than quantitative measures like residual moisture content or Tg′ values. This discrepancy between qualitative and quantitative data complicates efforts to synthesize results and perform statistical analyses. It also makes it harder to measure the overall effectiveness of lyoprotectants based on objective metrics. Incomplete data are another limitation that is vital. Some studies do not report all the necessary data points needed for thorough analysis, such as specific lyoprotectant concentrations, storage conditions, or the statistical significance of findings. Missing data pose significant challenges when trying to assess the efficacy of lyoprotectants or compare results across studies, thereby hindering comprehensive assessments.
One of the challenges in conducting systematic reviews is identifying and removing duplicate studies, which is both time-consuming and essential to avoid data redundancy. Some studies may also have overlapping data or could be extensions of previous research, which can lead to redundancy in the analysis. Many studies on lyoprotectants fail to consistently report critical data, such as key outcomes, experimental conditions, and methods. This inconsistency makes it difficult to compare studies directly, complicating the synthesis of results and drawing conclusions about the overall effectiveness of different lyoprotectants. The rapidly evolving field is also a challenge faced by the authors. The field of lyophilization and lyoprotectant research is constantly evolving, with new techniques and formulations emerging regularly. This dynamic nature poses a challenge for maintaining an up-to-date systematic review, as new studies continuously add to the body of knowledge. Keeping pace with these developments while ensuring the relevance of the review is difficult. The effectiveness of lyoprotectants is highly context-specific, depending on various factors like the type of protein being stabilized, the specific lyophilization process used, and the environmental conditions during drying. This specificity can limit the generalizability of the findings, as results from one study may not be directly applicable to another set of proteins or conditions.
The research reviewed provides strong evidence that lyoprotectants with higher Tg′ values and effective water-replacement abilities significantly enhance protein stability and maintain structural integrity during lyophilization. Lyoprotectants with high Tg′ values, such as disaccharides (e.g., sucrose, trehalose), polyols (e.g., maltitol), and certain trisaccharides, provide a stable amorphous matrix that protects proteins from denaturation and aggregation. The glassy state achieved by these lyoprotectants prevents molecular mobility, thereby reducing protein degradation. Higher Tg′ values correlate with better retention of protein structure and activity, which is crucial for ensuring the therapeutic efficacy and shelf-life of biopharmaceuticals. Sugars like sucrose and trehalose can effectively replace water molecules, forming hydrogen bonds with polar groups on protein surfaces. This substitution stabilizes the protein’s tertiary and secondary structures, mitigating the stress induced by drying and freezing processes. Studies have shown that trehalose forms fewer hydrogen bonds with proteins than sucrose, resulting in less disruption of protein structure, highlighting the importance of the specific interactions between lyoprotectants and proteins. Achieving a stable and visually acceptable cake structure is vital for the quality of lyophilized products. A combination of lyoprotectants, such as sucrose, trehalose, and mannitol, has been shown to create uniform, porous, and spongy cake structures. These structures facilitate efficient rehydration and preserve protein activity. The addition of surfactants like Tween-80 can further enhance cake properties by improving porosity and reducing moisture content, leading to better protein protection. The exploration of less common lyoprotectants, such as calcium ions, antifreeze glycopeptide analogues (GAPP), and antiplasticized polymeric glasses, offers new insights into protein stabilization strategies. These agents have shown promising results in enhancing protein stability by increasing glass transition temperatures, reducing cellular damage during lyophilization, and preserving enzymatic activities under various storage conditions. The synergistic effect of combining different lyoprotectants, such as the mixture of sucrose and trehalose or the addition of mannitol, enhances the overall protective effect. These combinations can provide dual functionality as cryo- and lyo-stabilizers, offering comprehensive protection across a range of temperatures and conditions. In summary, the selection of lyoprotectants based on their Tg′ values, water replacement abilities, and compatibility with the target protein can significantly impact the stability and efficacy of lyophilized pharmaceutical formulations. Future research should continue to explore novel lyoprotectants and their combinations to optimize lyophilization processes and extend the shelf-life of protein-based therapeutics.
The authors thank the members of DTERM for their guidance and support in generating this systematic review.
The following supporting information can be downloaded at:
Conceptualization, V.K., N.H.B.A.R., N.A.H.A. and M.M.; validation, M.B.F. and M.M.; writing—original draft preparation, V.K. and M.M.; drawings of figures, V.K. and N.H.B.A.R.; writing—review and editing, V.K., N.H.B.A.R., N.A.H.A., M.B.F., A.N.M.H., Y.L. and M.M.; visualization and supervision, M.B.F., A.N.M.H. and M.M.; project administration, M.M.; funding acquisition, M.M. All authors have read and agreed to the published version of the manuscript.
The authors declare no conflicts of interest.
This study was funded through the UKM Research Grant GGPM-2021-022 and GUP-2023-065.